What Your MD Doesn’t Tell You Can Harm You Our

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
183
What Your MD Doesn’t Tell You Can Harm You

Our corrupt medial system

https://www.naturalblaze.com/2017/11/md-doesn...-harm.html

By Catherine J. Frompovich

The opioid problems notwithstanding, has it ever occurred to healthcare consumers and allopathic medicine’s patients as to why you aren’t told the warnings, contraindications or adverse effects regarding the Rx-prescription MDs give you, often as many as 3 “scripts” at a time, when no studies have been done to determine if there are adverse reactions or contraindications from taking various chemical pharmaceuticals and legal drugs simultaneously?

Doctors are swift to advise patients about not taking vitamins, supplements, herbal and natural remedies—that’s a known given. However, are they as quick to tell patients about the chemicals they are prescribing, often willy-nilly-like and as guesstimates? Furthermore, how many times are there prescription adverse reactions, especially with the elderly, probably resulting due to what Big Pharma’s sales reps pitch to physicians about mainstreaming new drugs or the kick-backs docs will receive for prescribing them?

By the way, the FDA maintains a reporting system called FAERS—FDA Adverse Event Reporting System—whereby “medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.” However, FAERS seems to be a ‘clandestine’ and well-guarded database since one must file a FOIA report to look at the data . Hmmm! What does that tell you?

However, there is one caution MDs are fairly astute at telling patients which relates to taking grapefruit juice with certain prescription drugs. Grapefruit has the ability to decrease a pharmaceutical drug’s breakdown for elimination due to furanocoumarins, which block the CYP3A4 enzymes. This website provides a list of common drug-grapefruit interactions that, if you are taking prescriptions, you may want to print and keep.

Rx’s ability to impact driving a vehicle

Nevertheless, there is other information which MDs and pharmacists should be warning patients about and that is prescription drugs ability to impair one’s driving a motor vehicle and driving-related risk perceptions!

An October 31, 2017 study report titled “Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers” published in the Journal of Studies on Alcohol and Drugs described findings which ought to revolutionize the protocols for which pharmaceuticals are prescribed and dispensed by MDs and pharmacists alike.

The study Results found

Receipt of warnings varied by sex, race/ethnicity, income, geographic region, and time of day. For a majority of drug categories, drivers who reported receiving warnings had significantly higher odds of perceived risk of impaired driving/crash and criminal justice involvement.
It’s in the study’s Conclusions that we find one of the problems, plus pitfalls, with MDs having to push patients through their treatment rooms every twenty minutes or less:

Most users of prescription medications reported that the drug was prescribed for their use, but not all reported receiving warnings about driving impairment. Our study provides evidence of missed opportunities for information provision on impaired driving, identifies subgroups that may warrant enhanced interventions, and provides preliminary evidence that receipt of impairment warnings is associated with increased perceptions of driving-related risk.

[CJF emphasis]
MDs should be mandated by law and the AMA to give patients comprehensive warnings

But patient warnings regarding prescription medications associated with risk perceptions – for how serious that omission is for Rx-prescribed pharmaceuticals –actually pales compared with the oversight, neglect and downright deliberate refusal to instruct parents, guardians and intended vaccinees about the adverse reactions, contraindications, precautions and warnings printed in all vaccine package inserts.

How come that recent study published in the Journal of Studies on Alcohol and Drugs neglected to include vaccines?
Aren’t vaccines pharmaceuticals made by Big Pharma? Why are vaccines always EXEMPT from disclosure and patient discussions by MDs, nurses or those who administer vaccines from telling the scientific facts about adverse reactions, contraindications, precautions and warnings printed in vaccine package inserts?

The medical profession’s standard vaccine information mantra is “they are safe and effective.” Nothing is further from the facts as reported by the CDC/FDA VAERS (Vaccine Adverse Event Reporting System) and the HHS HRSA (Health Resources and Services Administration) Data and Statistics, which documents over $3.3+ BILLION paid out in claims (pg. 9) for vaccine injuries and/or deaths.

Medicare over-prescription and ‘abuse’

Here’s an example of Medicare patients prescription drug use:

The average Medicare Part D patient filled 49 standardized 30-day prescriptions in 2010. At the high end, patients in Miami, filled an average of 63 prescriptions, compared to patients in Grand Junction, Colo., who filled 39 prescriptions per year. [1]
According to the CDC website Therapeutic Drug Use, it seems we have a serious legal drug problem in the USA, which needs to be placed at the feet of the medical profession, especially MDs who get kick-backs and financial rewards for prescribing Rxs and the pharmaceutical industries incessant media advertising for Rx drugs.

Percent of persons using at least one prescription drug in the past 30 days: 48.9% (2011-2014)

Percent of persons using three or more prescription drugs in the past 30 days: 23.1% (2011-2014)

Percent of persons using five or more prescription drugs in the past 30 days: 11.9% (2011-2014)
Five or more prescription drugs in the past 30 days! Is there any wonder most senior citizens, especially those in nursing homes or other personal-care-type facilities, are drugged up like zombies?

If allopathic medicine and its acolytes are into science-based medicine, then where are the studies documenting no biochemical and/or physiological interactions when taking five or more chemical drugs simultaneously? Is that why the FAERS data is secretive?

Children’s Rx prescriptions and vaccines

Let’s not forget the kiddies! How many are taking prescription drugs and are they really necessary?

According to the CDC’s website

Seven and one-half [7.5] percent of children aged 6–17 years used prescribed medication during the past 6 months for emotional or behavioral difficulties. [CJF emphasis]
Something definitely is ethically and physiologically wrong to produce the above stats, in my opinion.

If children literally weren’t being poisoned with neurotoxic chemicals in vaccines at 2, 4 and 6 months of age and thereafter, plus not given chemical-laced water [2] and GMO ‘phood’, but taught to eat a nutritiously balanced diet not dependent on junk and sugar edibles or fried fast food restaurant offerings, most of those meds undoubtedly would not be necessary!

You can’t poison a body into wellness. But then that would not be profitable for Big Pharma and the MDs who prescribe them. Would it?

References:

[1] https://www.rwjf.org/en/library/articles-and-...isten.html
[2] http://www.fluoridation.com/quotes.htm

Resources:

“Follow The Money”: Big Pharma Swindles Insurance, Medicare and Consumers
https://www.activistpost.com/2017/10/follow-m...umers.html

Congress Is To Blame For The Opioid Epidemic Plus All Vaccine Tragedies; Investigate Both Now
https://www.activistpost.com/2017/10/congress...e-now.html

Will Opioid Lawsuits By County Officials Against Big Pharma Set Legal Precedent To Sue Vaccine Makers?
https://www.activistpost.com/2017/09/will-opi...akers.html

Catherine J Frompovich (website) is a retired natural nutritionist who earned advanced degrees in Nutrition and Holistic Health Sciences, Certification in Orthomolecular Theory and Practice plus Paralegal Studies. Her work has been published in national and airline magazines since the early 1980s. Catherine authored numerous books on health issues along with co-authoring papers and monographs with physicians, nurses, and holistic healthcare professionals. She has been a consumer healthcare researcher 35 years and counting.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Updated Category News Views 5

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

Continue Reading
GALY Expands Cocoa Operations US, UAE in 2026

Updated Category News Views 3

The Evolution of GALY's Cocoa Strategy Alright, let's talk chocolate—a staple that somehow turned into high-tech business news. GALY is stepping up its game big time, pushing its cultured cocoa front into both the U.S. and the UAE. If you ask me, it's a smart move, adding some resilience to the cocoa supply chain that otherwise dances on the whims of Mother Nature. GALY...

Continue Reading
LogiSense Secures Top Spot in 2026 Billing Solutions Guide

Updated Category News Views 4

LogiSense Gets High Marks in MGI Research Guide Well, here we go. LogiSense is making waves in the enterprise billing scene, snagging a top-five spot in MGI Research's 2026 Agile Billing Top 50 Buyer's Guide. The Kitchener-based outfit has been recognized not just for its strength in handling billing volumes, but for its top-notch capability in solution strength. Their...

Continue Reading
Workday's $2.5B Notes Move: What's the Play?

Updated Category News Views 10

Workday's Strategic Financial Maneuver When a company like Workday starts shaking the trees for $2.5 billion through a senior notes offering, you better believe traders like me are perking up and paying attention. We're talking a registered public offering, no less, which isn't peanuts. With such a substantial move, it's clear Workday (NASDAQ: WDAY) is setting its sights...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 5

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 2

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
NAFTZ Conference Spotlights Trade Zones Amid Policy Shifts

Updated Category News Views 7

The story ripping through San Diego at the NAFTZ conference? America's trade zones aren't just back in the game—they're smarter and sharper amid the trade policy chaos. The National Association of Foreign-Trade Zones hit a record with 600 attendees, and it's a damn clear sign that these zones are hot on the radar. Policy Shifts and Knuckle-Down Discussions These zones...

Continue Reading
Duolingo Faces Class Action: Investors Brace for Impact

Updated Category News Views 5

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 7

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading
Lazard's Q3 2026: Surging Revenue, Waning Net Income

Updated Category News Views 4

Breaking Down the Numbers Lazard just dropped its Q3 2026 earnings report, and you can smell both optimism and caution in the air. Sure, $814 million in net revenue isn’t anything to sneeze at, especially when it’s a neat 9% jump from last year’s $748 million. Adjusted figures were a whisker away at $805 million. But dig deeper, and things get a tad less rosy—net...

Continue Reading

Top 5 Most Recently Viewed Articles

NameSilo Technologies Corp. Celebrates Loan Repayment Milestone

Updated Category News Views 64

NameSilo Technologies Corp. Celebrates Loan Repayment Milestone CSE: URL / OTC: URLOF NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) has successfully repaid its outstanding loan of $3.9 million ahead of the maturity date, showcasing the company's strong financial health and strategic planning. This repayment was primarily funded through the consistent cash...

Continue Reading
Andrew Ridgeley Celebrates 40 Years of 'Last Christmas'

Updated Category News Views 148

40 Years of Last Christmas Celebrated by Albert Heijn In a heartwarming nod to holiday traditions, Albert Heijn, the leading supermarket chain, commemorates the 40th anniversary of Wham!'s beloved song, 'Last Christmas'. This Christmas season, the brand presents an imaginative reinterpretation of the song's iconic music video featuring a special appearance by Andrew...

Continue Reading
Curaçao: Thriving Tourism Sets Stage for Exciting 2025

Updated Category News Views 254

Curaçao's Bright Future: Aiming for Excellence in 2025 Curaçao, one of the enchanting islands of the Dutch Caribbean, is gearing up for a remarkable year ahead. Following a record-breaking influx of tourists, the island has laid the groundwork to elevate its hospitality offerings and overall visitor experience. The year 2024 marked a significant milestone as Curaçao...

Continue Reading
Stock Market Surge: Wayfair and Others on the Rise Today

Updated Category News Views 143

Market Overview and Notable Upward Trends U.S. stock markets experienced a positive day with the Dow Jones index increasing by approximately 400 points. This surge has led many investors to closely monitor key stocks as they report performance metrics that may impact future movements. Wayfair Inc.'s Performance Shares of Wayfair Inc. (W) demonstrated a remarkable rise...

Continue Reading
Traders Grapple with Rising Treasury Yields and Inflation Risks

Updated Category News Views 78

The current economic environment had traders scrambling in 2024 as inflation fears crept back into the conversation, undermining the once-popular 'no landing' scenario. This notion—the belief that the economy could thrive without hitting a recession—seemed increasingly fragile as preliminary data surfaced, showing robust job growth, falling unemployment, and rising...

Continue Reading